Abstract
Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic-General Recommendation Based on Available Evidence.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have